Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.845
+0.095 (5.43%)
Jan 22, 2026, 12:58 PM EST - Market open
Palisade Bio Market Cap
Palisade Bio has a market cap or net worth of $274.91 million as of January 22, 2026. Its market cap has increased by 5,131.06% in one year.
Market Cap
274.91M
Enterprise Value
279.58M
1-Year Change
5,131.06%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since April 28, 2021, Palisade Bio's market cap has increased from $75.07M to $274.91M, an increase of 266.21%. That is a compound annual growth rate of 31.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 260.76M | -25.53% |
| Dec 31, 2025 | 350.16M | 7,572.39% |
| Dec 31, 2024 | 4.56M | -16.56% |
| Dec 29, 2023 | 5.47M | -31.77% |
| Dec 30, 2022 | 8.02M | -54.57% |
| Dec 31, 2021 | 17.65M | -76.49% |
| Apr 28, 2021 | 75.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shattuck Labs | 279.70M |
| Neurogene | 279.28M |
| Rezolute | 278.65M |
| Nautilus Biotechnology | 276.61M |
| Atea Pharmaceuticals | 275.01M |
| Silence Therapeutics | 269.23M |
| Heron Therapeutics | 267.71M |
| Crescent Biopharma | 267.63M |